Press Releases

• November 10, 2022
  

  C-Path and EFACTS Announce Data Sharing Agreement Making RDCA-DAP the Largest Worldwide Database for Friedreich’s Ataxia

  C-Path and EFACTS today announced a data sharing agreement to incorporate patient data into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), solidifying RDCA-DAP as the largest worldwide database for Friedreich’s ataxia.

• November 2, 2022
  

  C-Path and Eisai Data Sharing Collaboration to Include Lennox-Gastaut Syndrome Registry and Clinical Trial Data

  TUCSON, Ariz., Nov. 2, 2022 — Critical Path Institute (C-Path) and the Eisai Co., Ltd. (Eisai) today announced a joint collaboration to significantly promote data sharing and incorporate Lennox-Gastaut Syndrome (LGS) clinical trial data, into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®). Lennox-Gastaut syndrome is a severe form of epilepsy with seizures occurring...
• October 31, 2022
  

  FDA Expands Support of C-Path CDRC to Automate EHR Data Extraction

  C-Path CURE Drug Repurposing Collaboratory (CDRC) has received additional funds as part of a new U.S. Food and Drug Administration (FDA) Health and Human Services (HHS) grant. This funding will support the development of partnerships with clinical and technical consultants and data providers, to capture the most critical COVID-19 treatment data from electronic healthcare records (EHR) and registries.

• October 27, 2022
  

  C-Path Appoints Neuropharmacology Expert as New Vice President – Rare and Orphan Disease Programs

  C-Path today announced the appointment of Collin Hovinga, Pharm.D., MS, FCCP as Vice President for its Rare and Orphan Disease Programs, and lead for both its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) initiative and Critical Path for Rare Neurodegenerative Diseases (CP-RND) public-private partnership. RDCA-DAP focuses on rare disease data sharing and accelerating therapy development. CP-RND focuses on the accelerating the development of therapies for patients living with rare neurodegenerative diseases, including ALS.

• October 20, 2022
  

  C-Path’s Ramona Walls Promoted to Executive Director of Data Science

  C-Path has named Ramona L. Walls, Ph.D., as Executive Director of Data Science within C-Path’s Data Collaboration Center (DCC).